HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,697,568 | +13.7% | 31,961 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $3,253,248 | -88.6% | 31,631 | -87.9% | 0.00% | -88.2% |
| Q1 2023 | $28,534,653 | -24.5% | 261,450 | -21.2% | 0.03% | -27.7% |
| Q4 2022 | $37,777,845 | +1806.0% | 331,967 | +950.1% | 0.05% | +2250.0% |
| Q3 2022 | $1,982,000 | -19.9% | 31,614 | +1.9% | 0.00% | -33.3% |
| Q2 2022 | $2,475,000 | -29.4% | 31,033 | -6.9% | 0.00% | 0.0% |
| Q1 2022 | $3,508,000 | -2.5% | 33,341 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $3,599,000 | -5.8% | 33,398 | -4.3% | 0.00% | -25.0% |
| Q3 2021 | $3,822,000 | +10.9% | 34,887 | +1.3% | 0.00% | +33.3% |
| Q2 2021 | $3,445,000 | +14.6% | 34,447 | +5.5% | 0.00% | 0.0% |
| Q1 2021 | $3,006,000 | +22.5% | 32,665 | -2.6% | 0.00% | 0.0% |
| Q4 2020 | $2,453,000 | -33.5% | 33,535 | -29.3% | 0.00% | -40.0% |
| Q3 2020 | $3,687,000 | +43.7% | 47,463 | +2.8% | 0.01% | +25.0% |
| Q2 2020 | $2,566,000 | – | 46,163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |